| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -36,980 | -11,034 | -28,356 | -56,048 |
| Depreciation, amortization and accretion | 19,875 | 18,332 | 17,168 | 38,516 |
| Net loss on disposal of property and equipment, net of insurance recoveries, and impairment expense | -3,761 | -4,738 | -4,409 | -4,518 |
| Share-based compensation | 4,245 | 7,552 | 7,033 | 12,525 |
| Bad debt expense | 989 | 6,062 | NaN | NaN |
| Change in fair value of earnout liability | -22 | -352 | 0 | -568 |
| Change in fair value of warrant liabilities | -934 | -2,092 | -574 | -5,704 |
| Paid-in-kind interest, amortization of deferred debt issuance costs, net of capitalized interest | 1,631 | 1,333 | 1,202 | 1,401 |
| Gain on sales-type lease | 4,321 | 38 | 287 | 2,500 |
| Write off of equity issuance costs | NaN | 786 | NaN | NaN |
| Other | 408 | 11 | 67 | -83 |
| Accounts receivable, net | -4,323 | 4,605 | 8,224 | -13,988 |
| Prepaids and other current assets and other assets | 8,335 | 2,448 | 10,119 | 4,643 |
| Operating lease assets and liabilities, net | 146 | -573 | -256 | 121 |
| Accounts payable | 5,359 | -4,368 | 3,506 | -4,875 |
| Accrued liabilities | -15,134 | 9,287 | -6,112 | 8,737 |
| Deferred revenue | -8,963 | -11,794 | -1,935 | -224 |
| Other current and noncurrent liabilities | -308 | -664 | -728 | -1,242 |
| Net cash used in operating activities | -35,368 | 11,257 | -22,828 | 3,843 |
| Capital expenditures | 30,575 | 49,364 | 26,152 | 41,191 |
| Proceeds from insurance for property losses | 13 | 0 | 0 | 24 |
| Net cash used in investing activities | -30,562 | -49,364 | -26,152 | -41,167 |
| Proceeds from long-term debt | 3,365 | 47,358 | 59,356 | 94,180 |
| Payments on long-term debt | 250 | NaN | NaN | NaN |
| Proceeds from capital-build funding | 3,196 | 1,073 | 5,044 | 9,051 |
| Contribution from redeemable noncontrolling interest | NaN | -1 | 9,563 | NaN |
| Payments of withholding tax on net issuance of restricted stock units | 991 | 286 | 89 | 529 |
| Payments of deferred debt issuance costs | 137 | 425 | 7,137 | 2,513 |
| Net cash provided by financing activities | 5,183 | 47,719 | 66,737 | 100,189 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -60,747 | 9,612 | 17,757 | 62,865 |
| Cash, cash equivalents and restricted cash, beginning of period | 210,746 | 201,134 | 120,512 | NaN |
| Cash, cash equivalents and restricted cash, end of period | 149,999 | 210,746 | 201,134 | NaN |
EVgo Inc. (EVGO)
EVgo Inc. (EVGO)